BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19570562)

  • 1. Immune evasion proteins gpUS2 and gpUS11 of human cytomegalovirus incompletely protect infected cells from CD8 T cell recognition.
    Besold K; Wills M; Plachter B
    Virology; 2009 Aug; 391(1):5-19. PubMed ID: 19570562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Processing and MHC class I presentation of human cytomegalovirus pp65-derived peptides persist despite gpUS2-11-mediated immune evasion.
    Besold K; Frankenberg N; Pepperl-Klindworth S; Kuball J; Theobald M; Hahn G; Plachter B
    J Gen Virol; 2007 May; 88(Pt 5):1429-1439. PubMed ID: 17412970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of CD8+ T-cell recognition in the immediate-early phase of human cytomegalovirus infection.
    Hesse J; Ameres S; Besold K; Krauter S; Moosmann A; Plachter B
    J Gen Virol; 2013 Feb; 94(Pt 2):376-386. PubMed ID: 23100361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
    Wills MR; Carmichael AJ; Mynard K; Jin X; Weekes MP; Plachter B; Sissons JG
    J Virol; 1996 Nov; 70(11):7569-79. PubMed ID: 8892876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.
    Gibson L; Piccinini G; Lilleri D; Revello MG; Wang Z; Markel S; Diamond DJ; Luzuriaga K
    J Immunol; 2004 Feb; 172(4):2256-64. PubMed ID: 14764694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
    Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
    J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
    Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
    Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus pp71 stimulates major histocompatibility complex class i presentation of IE1-derived peptides at immediate early times of infection.
    Hesse J; Reyda S; Tenzer S; Besold K; Reuter N; Krauter S; Büscher N; Stamminger T; Plachter B
    J Virol; 2013 May; 87(9):5229-38. PubMed ID: 23449799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides.
    Kern F; Faulhaber N; Frömmel C; Khatamzas E; Prösch S; Schönemann C; Kretzschmar I; Volkmer-Engert R; Volk HD; Reinke P
    Eur J Immunol; 2000 Jun; 30(6):1676-82. PubMed ID: 10898504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-presentation of human cytomegalovirus pp65 (UL83) to CD8+ T cells is regulated by virus-induced, soluble-mediator-dependent maturation of dendritic cells.
    Arrode G; Boccaccio C; Abastado JP; Davrinche C
    J Virol; 2002 Jan; 76(1):142-50. PubMed ID: 11739680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.
    Tabi Z; Moutaftsi M; Borysiewicz LK
    J Immunol; 2001 May; 166(9):5695-703. PubMed ID: 11313411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion.
    Ameres S; Mautner J; Schlott F; Neuenhahn M; Busch DH; Plachter B; Moosmann A
    PLoS Pathog; 2013; 9(5):e1003383. PubMed ID: 23717207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response.
    Retière C; Prod'homme V; Imbert-Marcille BM; Bonneville M; Vié H; Hallet MM
    J Virol; 2000 May; 74(9):3948-52. PubMed ID: 10756006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus.
    Frankenberg N; Pepperl-Klindworth S; Meyer RG; Plachter B
    Virology; 2002 Apr; 295(2):208-16. PubMed ID: 12033779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4
    Frascaroli G; Lecher C; Varani S; Setz C; van der Merwe J; Brune W; Mertens T
    Front Immunol; 2018; 9():1129. PubMed ID: 29887865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs.
    Gyulai Z; Endresz V; Burian K; Pincus S; Toldy J; Cox WI; Meric C; Plotkin S; Gönczöl E; Berencsi K
    J Infect Dis; 2000 May; 181(5):1537-46. PubMed ID: 10823751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-presentation of HCMV chimeric protein enables generation and measurement of polyclonal T cells.
    Nguyen TH; Sullivan LC; Kotsimbos TC; Schwarer AP; Mifsud NA
    Immunol Cell Biol; 2010 Aug; 88(6):676-84. PubMed ID: 20195281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
    Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
    J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules.
    Sinzger C; Eberhardt K; Cavignac Y; Weinstock C; Kessler T; Jahn G; Davignon JL
    J Gen Virol; 2006 Jul; 87(Pt 7):1853-1862. PubMed ID: 16760387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.
    Jouand N; Bressollette-Bodin C; Gérard N; Giral M; Guérif P; Rodallec A; Oger R; Parrot T; Allard M; Cesbron-Gautier A; Gervois N; Charreau B
    PLoS Pathog; 2018 Apr; 14(4):e1007041. PubMed ID: 29709038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.